Immunomodulatory and Anti-Inflammatory Effects of Gabapentin: A Systematic Review and Risk of Bias Analysis of Preclinical Studies
Immuno · 21.04.2026 · 6 (2) · 30
DOI: 10.3390/immuno6020030 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Immuno, online erschienen am 21.04.2026. Verfasst von Annette d’Arqom und 8 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indonesia Endowment Fund for Education, International Research Collaboration.
Abstract (Originalsprache)
Gabapentin is widely used for epilepsy and neuropathic pain. Beyond neurological indications, preclinical evidence suggests that gabapentin may exert anti-inflammatory effects that have not been systematically reviewed. A systematic review (2015–2025) was performed, resulting in thirteen in vitro and in vivo studies evaluating gabapentin’s impact on inflammatory signaling pathways, cytokine production, immune cell activity, and tissue inflammation. Outcomes included molecular pathways, inflammatory mediators, histopathological changes, and functional inflammatory measures. Risk of bias and study quality were assessed using the SYRCLE RoB tool for in vivo studies and the SciRAP approach for in vitro studies. Gabapentin demonstrated potential modulation of inflammatory responses in neuropathic pain, neuroinflammation, uveitis, and sepsis models through inhibition of MAPK and NF-κB signaling, reduction in pro-inflammatory cytokines, modulation of PPAR signaling pathways, and activation of Nrf2/HO-1 pathway. Gabapentin’s pharmacological actions extend beyond neuronal excitability to include modulation of inflammatory pathways, supporting a broader biological role for gabapentin. Although preclinical data support gabapentin’s potential anti-inflammatory properties, further targeted experimental and clinical studies are warranted to confirm these findings.
Förderung
- Indonesia Endowment Fund for Education
- International Research Collaboration
Zitieren
APA
d’Arqom, A., Rizky, K. A., Aqilah, N. M., Huda, F., Lee, M. T., Tansy, B. A., Noor, S. M., Rimbun, & Megasari, N. L. A. (2026). Immunomodulatory and Anti-Inflammatory Effects of Gabapentin: A Systematic Review and Risk of Bias Analysis of Preclinical Studies. Immuno, 6(2), 30. https://doi.org/10.3390/immuno6020030
Vancouver
d’Arqom A, Rizky KA, Aqilah NM, Huda F, Lee MT, Tansy BA, et al. Immunomodulatory and Anti-Inflammatory Effects of Gabapentin: A Systematic Review and Risk of Bias Analysis of Preclinical Studies. Immuno. 2026;6(2):30. doi:10.3390/immuno6020030
BibTeX
@article{dArqom2026,
author = {d’Arqom, Annette and Rizky, Kireina Azizah and Aqilah, Nasya Malfa and Huda, Fathul and Lee, Ming Tatt and Tansy, Belinda Anasthasya and Noor, Suzita Mohd and Rimbun and Megasari, Ni Luh Ayu},
title = {Immunomodulatory and Anti-Inflammatory Effects of Gabapentin: A Systematic Review and Risk of Bias Analysis of Preclinical Studies},
journal = {Immuno},
year = {2026},
volume = {6},
number = {2},
pages = {30},
doi = {10.3390/immuno6020030}
}
EUVIMED